Shmuel Miron

774 total citations
25 papers, 567 citations indexed

About

Shmuel Miron is a scholar working on Pathology and Forensic Medicine, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Shmuel Miron has authored 25 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 10 papers in Immunology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Shmuel Miron's work include Multiple Sclerosis Research Studies (12 papers), Peripheral Neuropathies and Disorders (7 papers) and Cell Adhesion Molecules Research (7 papers). Shmuel Miron is often cited by papers focused on Multiple Sclerosis Research Studies (12 papers), Peripheral Neuropathies and Disorders (7 papers) and Cell Adhesion Molecules Research (7 papers). Shmuel Miron collaborates with scholars based in Israel, United States and Italy. Shmuel Miron's co-authors include Anat Achiron, Mark Dolev, Ofer Lider, Rami Hershkoviz, Anat Biegon, Shay Menascu, Vered Lavie, Raanan Margalit, Shlomo Flechter and Rina Falb and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and European Journal of Immunology.

In The Last Decade

Shmuel Miron

25 papers receiving 550 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Shmuel Miron 248 185 173 111 87 25 567
H. Link 139 0.6× 72 0.4× 179 1.0× 373 3.4× 63 0.7× 41 862
Sarah Laurent 360 1.5× 120 0.6× 371 2.1× 213 1.9× 69 0.8× 19 828
Katherine L. Neville 346 1.4× 65 0.4× 90 0.5× 770 6.9× 103 1.2× 15 1.3k
Stefan Blum 123 0.5× 179 1.0× 685 4.0× 162 1.5× 48 0.6× 61 1.1k
Elisabetta Zardini 442 1.8× 66 0.4× 446 2.6× 180 1.6× 51 0.6× 43 1.1k
Jillian E. Wohler 79 0.3× 50 0.3× 39 0.2× 182 1.6× 80 0.9× 16 483
Rana Zabad 333 1.3× 21 0.1× 166 1.0× 92 0.8× 42 0.5× 34 722
Suzanne Gazda 621 2.5× 48 0.3× 273 1.6× 362 3.3× 110 1.3× 13 1.0k
Lorne F. Kastrukoff 436 1.8× 25 0.1× 115 0.7× 390 3.5× 62 0.7× 26 945
Yuri Nakamura 226 0.9× 90 0.5× 175 1.0× 115 1.0× 16 0.2× 30 521

Countries citing papers authored by Shmuel Miron

Since Specialization
Citations

This map shows the geographic impact of Shmuel Miron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shmuel Miron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shmuel Miron more than expected).

Fields of papers citing papers by Shmuel Miron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shmuel Miron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shmuel Miron. The network helps show where Shmuel Miron may publish in the future.

Co-authorship network of co-authors of Shmuel Miron

This figure shows the co-authorship network connecting the top 25 collaborators of Shmuel Miron. A scholar is included among the top collaborators of Shmuel Miron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shmuel Miron. Shmuel Miron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dreyer-Alster, Sapir, Shay Menascu, Mathilda Mandel, et al.. (2022). COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose. Journal of the Neurological Sciences. 434. 120155–120155. 40 indexed citations
2.
Miron, Shmuel, et al.. (2019). Association Between White Matter Microstructure and Verbal Fluency in Patients With Multiple Sclerosis. Frontiers in Psychology. 10. 1607–1607. 30 indexed citations
3.
Menascu, Shay, et al.. (2018). Brain Lesion Load and Anatomic Distribution in Patients With Juvenile Clinically Isolated Syndrome Predicts Rapidly Advanced to Multiple Sclerosis. Journal of Child Neurology. 33(10). 633–638. 3 indexed citations
4.
Inglese, Matilde, Maria Petracca, Enricomaria Mormina, et al.. (2017). Cerebellar volume as imaging outcome in progressive multiple sclerosis. PLoS ONE. 12(4). e0176519–e0176519. 25 indexed citations
6.
Tal, Sigal, Shmuel Miron, Mark Dolev, Gil Harari, & Anat Achiron. (2010). Diffusion Tensor Imaging of Corpus Callosum Integrity in Multiple Sclerosis: Correlation with Disease Variables. Journal of Neuroimaging. 22(1). 33–37. 33 indexed citations
7.
Achiron, Anat & Shmuel Miron. (2005). Intravenous Immunoglobulin and Multiple Sclerosis. Clinical Reviews in Allergy & Immunology. 29(3). 247–254. 4 indexed citations
8.
Achiron, Anat, Shmuel Miron, & Yehuda Shoenfeld. (2005). Does the flap of a butterfly's wings in Brazil set off a tornado in Texas?--The JC Virus Story in multiple sclerosis.. PubMed. 7(5). 283–5. 7 indexed citations
9.
Barash, Judith, et al.. (2003). Tumor necrosis factor (TNF)α and its soluble receptor (sTNFR) p75 during acute human parvovirus B19 infection in children. Immunology Letters. 88(2). 109–112. 12 indexed citations
11.
Bank, Ilan, et al.. (2000). Parenteral Administration of an Activating Monoclonal Antibody to the α1β1 Integrin in Dogs. Immunobiology. 202(3). 239–253. 3 indexed citations
12.
Achiron, Anat, Shmuel Miron, Vered Lavie, Raanan Margalit, & Anat Biegon. (2000). Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis. Journal of Neuroimmunology. 102(1). 26–31. 65 indexed citations
13.
Achiron, Anat, Yoram Barak, Shmuel Miron, & I Sarova-Pinhàs. (2000). Immunoglobulin treatment in refractory myasthenia gravis. Muscle & Nerve. 23(4). 551–555. 41 indexed citations
14.
Achiron, Anat & Shmuel Miron. (2000). Immunoglobulins Treatment in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. Multiple Sclerosis Journal. 6(2_suppl). S6–S8. 7 indexed citations
15.
Hershkoviz, Rami, Ofer Lider, Dana Baram, et al.. (1994). Inhibition of T cell adhesion to extracellular matrix glycoproteins by histamine: a role for mast cell degranulation products. Journal of Leukocyte Biology. 56(4). 495–501. 13 indexed citations
16.
Hershkoviz, Rami, Liora Cahalon, Dalia Gilat, et al.. (1993). Physically Damaged Extracellular Matrix Induces TNF‐α Secretion by Interacting Resting CD4+ T Cells and Macrophages. Scandinavian Journal of Immunology. 37(1). 111–115. 28 indexed citations
17.
Hershkoviz, Rami, et al.. (1992). T lymphocyte adhesion to the fibronectin and laminin components of the extracellular matrix is regulated by the CD4 molecule. European Journal of Immunology. 22(1). 7–13. 21 indexed citations
19.
Miron, Shmuel, et al.. (1992). Involvement of a protein kinase C and protein phosphatases in adhesion of CD4+ T cells to and detachment from extracellular matrix proteins. Cellular Immunology. 144(1). 182–189. 16 indexed citations
20.
Lider, Ofer, Andrew S. Miller, Shmuel Miron, et al.. (1991). Nonencephalitogenic CD4-CD8- V alpha 2V beta 8.2+ anti-myelin basic protein rat T lymphocytes inhibit disease induction. The Journal of Immunology. 147(4). 1208–1213. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026